Skip to main content
. 2020 Oct 7;15:233. doi: 10.1186/s13014-020-01673-6

Table 3.

Adverse events

Adverse events Grade < 3, n (%) Grades 3 or 4, n (%)
White blood cells decreased 1 (3.3) 0
Hypotension 1 (3.3) 0
Diarrhea 6 (20) 0
Anorexia 1 (3.3) 0
Nausea 2 (6.7) 0
Abdominal distention 2 (6.7) 0
Abdominal pain 1 (3.3) 0
Anal pain 1 (3.3) 0
Constipation 1 (3.3) 0
Hemorrhoids 1 (3.3) 0
Vomiting 2 (6.7) 0
Chills 2 (6.7) 0
Fatigue 5 (16.7) 0
Fever 1 (3.3) 0
Gram negative Bacilli 1 (3.3) 0
UTI 1 (3.3) 0
Localized shoulder edema 1 (3.3) 0
Insomnia 2 (6.7) 0
Dizziness 1 (3.3) 0
Vaginal discharge 1 (3.3) 0
Vulvar infection-herpes 1 (3.3) 0
Upper respiratory tract infection 2 (6.7) 0
Cough 1 (3.3) 0
Dry skin 3 (10) 0
Rash 2 (6.7) 0
Palmar-plantar erythrodysesthesia syndrome 1 (3.3) 0
Skin irritation 1 (3.3) 0
Small intestinal obstruction 0 1 (3.3)
Colitis 0 1 (3.3)
Acute kidney injury 0 1 (3.3)